Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Goose94 who wrote (10933)	1/7/2015 9:45:12 AM
From: Andrew~	Read Replies (1) \| Respond to of 202704

PHM-V PHM Announces Execution of a Letter of Intent (LOI) to Acquire a Regional Business in the Southeast with $2.25 Million in Annualized Revenue; Untapped Patient Database for Cardiology Services LOS ANGELES, CALIFORNIA--(Marketwired - Jan. 7, 2015) - NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. Patient Home Monitoring Corp. (TSX VENTURE:PHM) ("PHM") announced it has executed a non-binding Letter of Intent (LOI) to acquire a company reporting unaudited 10 month annualized revenues of approximately $2,250,000 and Adjusted EBITDA margins in excess of 20%. This addition to our existing Georgia locations makes PHM a dominant provider of home-based health monitoring services in the state. The acquisition of this growing and profitable company is expected to be immediately accretive to the income statement and will increase PHM's earnings-per-share (EPS). As a result of this acquisition and the LOI announced on December 22nd, both expected to close in the first calendar quarter of 2015, PHM's annual revenue run rate is expected to be over $50,000,000 at the time of close. The business is focused on offering home-based pulmnology services for patients with sleep apnea, oxygen needs and other diseases of the lungs. After the acquisition, PHM expects continued strong organic Adjusted EBITDA growth from cross selling. According to the LOI, PHM expects to close the acquisition with approximately $1,500,000 in cash and approximately 650,000 PHM common shares depending on final due diligence of trailing 12 month Adjusted EBITDA. Closing the acquisitions will be subject to final due diligence and a binding purchase agreement. "With this acquisition, we continue our expansion across the lucrative southeast region of the US market," said Michael Dalsin, Chairman of PHM. "While this acquisition is smaller in size, we can use our regional expertise and infrastructure to achieve significant revenue and profit growth through offering cardiology and Complex COPD services. We are targeting this quarter to close this acquisition and the most recently announced LOI in the current quarter. I expect this will have an immediate positive impact on our growth. We have a very full pipeline of potential deals and we are continuing to grow our M&A department. I continue to believe we will close 5 deals this year, significantly increasing revenues, profits and, most importantly, earnings per share."